Appleton Partners Inc Biogen Inc. Transaction History

Appleton Partners Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 07, 2021	SELL	$259.0 - $414.71 $235,690 - $377,386	-910 Closed	0 $0
Q1 2021 Apr 19, 2021	SELL	$242.95 - $284.63 $25,266 - $29,601	-104 Reduced 10.26%	910 $255,000
Q4 2020 Jan 19, 2021	BUY	$236.26 - $355.63 $239,567 - $360,608	1,014 New	1,014 $248,000
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $215,463 - $285,344	-833 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$268.85 - $341.04 $40,327 - $51,156	-150 Reduced 15.26%	833 $264,000

Q4 2019 Jan 13, 2020	BUY	$220.06 - $304.07 $216,318 - $298,900	983 New	983 $292,000
Q2 2019 Jul 25, 2019	SELL	$219.29 - $241.72 $207,886 - $229,150	-948 Closed	0 $0
Q4 2018 Jan 17, 2019	SELL	$278.5 - $352.75 $681,489 - $863,179	-2,447 Reduced 72.08%	948 $285,000
Q3 2018 Oct 09, 2018	SELL	$293.51 - $383.83 $2,054 - $2,686	-7 Reduced 0.21%	3,395 $1.2 Million
Q2 2018 Aug 08, 2018	SELL	$257.52 - $306.91 $19,056 - $22,711	-74 Reduced 2.13%	3,402 $987,000
Q1 2018 Apr 11, 2018	BUY	$260.13 - $367.91 $24,452 - $34,583	94 Added 2.78%	3,476 $952,000
Q4 2017 Jan 12, 2018	BUY	$307.64 - $344.58 $3,999 - $4,479	13 Added 0.39%	3,382 $1.08 Million
Q3 2017 Oct 12, 2017	BUY	$281.15 - $329.69 $947,194 - $1.11 Million	3,369	3,369 $1.06 Million

1,047

126M

1.37M

1.35M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Appleton Partners Inc, based on Form 13F filings with the SEC.

Stay updated on Appleton Partners Inc with notifications on news.